Table 1. Distribution of Kaposi's sarcoma and non-Hodgkin's lymphoma cases and controls according to the matching variables.
|
Kaposi's sarcoma
|
Non-Hodgkin's lymphoma
|
|||
|---|---|---|---|---|
| Cases (N=189) | Controls (N=189) | Cases (N=67) | Controls (N=67) | |
| Sex | ||||
| Males | 189 | 189 | 61 | 61 |
| Females | 0 | 0 | 6 | 6 |
| Age (years) | ||||
| <30 | 33 | 38 | 20 | 15 |
| 30–34 | 55 | 53 | 14 | 21 |
| 35+ | 101 | 98 | 33 | 31 |
| HIV transmission group | ||||
| Homosexual | 188 | 188 | 12 | 12 |
| Othera | 1 | 1 | 55 | 55 |
| Study | ||||
| Concorde | 67 | 67 | 20 | 20 |
| Alpha | 56 | 56 | 17 | 17 |
| Delta | 66 | 66 | 30 | 30 |
| Ethnicity | ||||
| White | 182 | 180 | 64 | 62 |
| Otherb | 7 | 9 | 3 | 5 |
| Mean time (days) between first blood sample and date of diagnosis of cancer/pseudo-diagnosis in controls | 923 (standard deviation (s.d.) 725) | 965 (s.d. 713) | 957 (s.d. 786) | 977 (s.d. 795) |
| Time between 1st and 2nd sample (years) | ||||
| <2 | 53 | 53 | 30 | 29 |
| 2+ | 65 | 65 | 18 | 19 |
| NAc | 71 | 71 | 19 | 19 |
| CD4 count (at 1st sample) | ||||
| 500– | 33 | 45 | 4 | 14 |
| 200– | 74 | 84 | 29 | 27 |
| <200 | 56 | 34 | 17 | 9 |
| NKd | 26 | 26 | 17 | 17 |
Heterosexual/i.v. drug user/haemophiliac/blood transfusion/other blood contact/other.
Indian subcontinent/West Indian-Guyanan/African/other or mixed.
NA: not applicable.
NK: not known.